Community-based screening enhances hepatitis B virus linkage to care among West African migrants in Spain.
Journal
Communications medicine
ISSN: 2730-664X
Titre abrégé: Commun Med (Lond)
Pays: England
ID NLM: 9918250414506676
Informations de publication
Date de publication:
14 Dec 2023
14 Dec 2023
Historique:
received:
06
06
2023
accepted:
30
11
2023
medline:
15
12
2023
pubmed:
15
12
2023
entrez:
14
12
2023
Statut:
epublish
Résumé
Chronic infection with HBV is responsible for >50% of all hepatocellular cancer cases globally and disproportionately affects sub-Saharan African (sSA) countries. Migration from these countries to Europe has increased substantially in recent years, posing unique challenges to health systems. The aim of this study was to carry out a community-based intervention to increase HBV screening, vaccination, and linkage to care among sSA migrants in Catalonia, Spain. This was a prospective cohort study. Participants ≥18 years were offered community-based HBV screening between 20/11/20 and 21/01/22. Rapid HBV testing and blood sample collection utilizing plasma separation cards were carried out and linkage to care was offered to all participants. HBV vaccination and post-test counseling were performed at a second visit in the community. The main outcome was the odds of those with current HBV infection being successfully linked to hepatology. Rates of completing the care cascade of this model were analyzed. In the present study, 444 people undergo screening, with 50.6% of participants showing evidence of past or current HBV infection, including an HBsAg prevalence of 9.2%. Migrants with current HBV infection exhibit 5.2 times higher odds of successful linkage to care compared to those in need of post-test counseling or vaccination. The study achieves a successful linkage to care rate of 72% for all participants, with specialist appointments arranged within 15.5 days. This community-based HBV screening program provides evidence of a successful model for identifying and providing care, including vaccination, to west African migrants at high risk of HBV infection who may otherwise not engage in care. A large proportion of hepatitis B virus (HBV) infections occur within countries in sub-Saharan Africa. With recent increased migration from these countries to Catalonia Spain, the prevalence of HBV is greater in migrants than in host populations. However, migrants face additional barriers when trying to access care. We developed a community-based care pathway to provide migrants in Catalonia with access to HBV testing, post-test counseling, vaccinations, and appointments with specialists when needed. The results showed that this strategy was successful in increasing testing, linkage to care, and vaccination among at-risk migrant populations in Catalonia, Spain. It may be worthwhile implementing this strategy on a wider scale and with other at-risk populations to reduce HBV infections and improve outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Chronic infection with HBV is responsible for >50% of all hepatocellular cancer cases globally and disproportionately affects sub-Saharan African (sSA) countries. Migration from these countries to Europe has increased substantially in recent years, posing unique challenges to health systems. The aim of this study was to carry out a community-based intervention to increase HBV screening, vaccination, and linkage to care among sSA migrants in Catalonia, Spain.
METHODS
METHODS
This was a prospective cohort study. Participants ≥18 years were offered community-based HBV screening between 20/11/20 and 21/01/22. Rapid HBV testing and blood sample collection utilizing plasma separation cards were carried out and linkage to care was offered to all participants. HBV vaccination and post-test counseling were performed at a second visit in the community. The main outcome was the odds of those with current HBV infection being successfully linked to hepatology. Rates of completing the care cascade of this model were analyzed.
RESULTS
RESULTS
In the present study, 444 people undergo screening, with 50.6% of participants showing evidence of past or current HBV infection, including an HBsAg prevalence of 9.2%. Migrants with current HBV infection exhibit 5.2 times higher odds of successful linkage to care compared to those in need of post-test counseling or vaccination. The study achieves a successful linkage to care rate of 72% for all participants, with specialist appointments arranged within 15.5 days.
CONCLUSIONS
CONCLUSIONS
This community-based HBV screening program provides evidence of a successful model for identifying and providing care, including vaccination, to west African migrants at high risk of HBV infection who may otherwise not engage in care.
A large proportion of hepatitis B virus (HBV) infections occur within countries in sub-Saharan Africa. With recent increased migration from these countries to Catalonia Spain, the prevalence of HBV is greater in migrants than in host populations. However, migrants face additional barriers when trying to access care. We developed a community-based care pathway to provide migrants in Catalonia with access to HBV testing, post-test counseling, vaccinations, and appointments with specialists when needed. The results showed that this strategy was successful in increasing testing, linkage to care, and vaccination among at-risk migrant populations in Catalonia, Spain. It may be worthwhile implementing this strategy on a wider scale and with other at-risk populations to reduce HBV infections and improve outcomes.
Autres résumés
Type: plain-language-summary
(eng)
A large proportion of hepatitis B virus (HBV) infections occur within countries in sub-Saharan Africa. With recent increased migration from these countries to Catalonia Spain, the prevalence of HBV is greater in migrants than in host populations. However, migrants face additional barriers when trying to access care. We developed a community-based care pathway to provide migrants in Catalonia with access to HBV testing, post-test counseling, vaccinations, and appointments with specialists when needed. The results showed that this strategy was successful in increasing testing, linkage to care, and vaccination among at-risk migrant populations in Catalonia, Spain. It may be worthwhile implementing this strategy on a wider scale and with other at-risk populations to reduce HBV infections and improve outcomes.
Identifiants
pubmed: 38097770
doi: 10.1038/s43856-023-00420-8
pii: 10.1038/s43856-023-00420-8
doi:
Types de publication
Journal Article
Langues
eng
Pagination
182Informations de copyright
© 2023. The Author(s).
Références
World Health Organization. Global Hepatitis Report 2017. (accessed 10 Nov 2022); https://www.who.int/publications/i/item/9789241565455 .
Mukthinuthalapati, V. V. P. K. et al. Hepatocellular carcinoma in sub-Saharan Africa. JCO Glob. Oncol. 7, 756–766 (2021).
doi: 10.1200/GO.20.00425
International Organization on Migration (IOM). World Migration Report 2022. (accessed 9 Nov 2022); https://publications.iom.int/books/world-migration-report-2022 .
European Commission. Statistics on Migration to Europe. (accessed 9 Nov 2022); https://ec.europa.eu/info/strategy/priorities-2019-2024/promoting-our-european-way-life/statistics-migration-europe_en .
Instituto Nacional de Estadistica. Cifras de población a 1 de enero 2021. Estadisticas de migraciones, año 2020. (accessed 9 Nov 2022); https://www.ine.es/prensa/cp_e2021_p.pdf .
Picchio, C. A. et al. Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review. Sci. Rep. 11, 24133 (2021).
doi: 10.1038/s41598-021-01885-0
pubmed: 34921156
pmcid: 8683418
Mipatrini, D. et al. Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence. Pathog. Glob. Health 111, 59–68 (2017).
doi: 10.1080/20477724.2017.1281374
pubmed: 28165878
pmcid: 5375618
Baggaley, R. F. et al. Prevention and treatment of infectious diseases in migrants in Europe in the era of universal health coverage. Lancet Pub. Health 7, e876–e884 (2022).
doi: 10.1016/S2468-2667(22)00174-8
Dalmau-Bueno, A. et al. Frequency of Health-care service use and severity of illness in undocumented migrants in Catalonia, Spain: a population-based, cross-sectional study. Lancet Planet. Health 5, e286–e296 (2021).
doi: 10.1016/S2542-5196(21)00036-X
pubmed: 33964238
Mason, M. K. L. et al. Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: a systematic review. J. Viral Hepat. 26, 1431–1453 (2019).
doi: 10.1111/jvh.13182
pubmed: 31332919
pmcid: 6899601
World Health Organization. Global Health Sector Strategy (GHSS) on viral hepatitis, 2016-2021. (accessed 9 Nov 2022); https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf .
Picchio, C. A. et al. A novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in Spain. Sci. Rep. 11, 17063 (2021).
doi: 10.1038/s41598-021-96350-3
pubmed: 34433852
pmcid: 8387363
Instituto de Estadistica de Catalauña (IDESCAT). xtranjeros con tarjeta de residencia. Por país de nacionalidad. Provincias. (accessed 8 Feb 2023); https://www.idescat.cat/indicadors/?id=aec&n=15250&lang=es .
Raosoft sample size calculator. (accessed 14 September 2023); http://www.raosoft.com/samplesize.html .
World Health Organization. WHO prequalification of in vitro diagnostics- Public Report. WHO reference number: PQDx 0451-013-00. (Accessed 19 Dec 2022); https://extranet.who.int/pqweb/sites/default/files/200123_pqdx_0451_013_00_determine_hbsag_2_final_pqpr_v2.pdf (January 2020).
Rando, A. et al. Evaluation of dried plasma spot on the cobas® plasma separation card as a sample type for hepatitis B virus load quantification on the cobas® 6800 system. FRI381 EASL International Liver Conference 2020. (accessed 29 Mar 2023). https://www.journal-of-hepatology.eu/article/S0168-8278(20)31643-3/pdf .
Rando, A. et al. Evaluation of the whole blood spot on plasma separation card as a sample type for serological screening for hepatitis B and hepatitis D infection. Abstract 7262 ECCMID Conference 2020.
Campreciós, J. M. et al. Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitis. J. Virol. Methods 289, 114039 (2021).
doi: 10.1016/j.jviromet.2020.114039
Cui, F. et al. Global reporting of progress towards elimination of hepatitis B and hepatitis C. Lancet Gasroenterol. Hepatol. https://doi.org/10.1016/S2468-1253(22)00386-7 (2023).
Mason, L. K. M. et al. Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: a systematic review. J. Viral Hepat. 26, 1359–1501 (2019).
doi: 10.1111/jvh.13182
El Periodico. Estas son las listas de espera de los hospitales catalanes. (accessed 8 Feb 2023). https://www.elperiodico.com/es/sociedad/20221014/listas-espera-hospitales-catalanes-operaciones-pruebas-diagnosticas-77196400 (14 Oct 2022).
Martró, E. et al. Pilot hepatitis C micro-elimination strategy in Pakistani migrants in Catalonia through a community intervention. Liver Int. 42, 1751–1761 (2022).
doi: 10.1111/liv.15327
pubmed: 35635535
Colucci, G. et al. Italian migrants study: an HCV and HBV micro-elimination pilot project. Clin. Res. Hepatol. Gastroenterol. 46, 101852 (2022).
doi: 10.1016/j.clinre.2021.101852
pubmed: 34923181
World Health Organization (WHO). Guidelines on hepatitis B and C testing. (Geneva, 2017).
European Association for the Study of the Liver (EASL). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol. 67, 370–398 (2017).
doi: 10.1016/j.jhep.2017.03.021
European Centre for Disease Prevention and Control (ECDC). Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA 2018. (accessed 22 Dec 2022); https://www.ecdc.europa.eu/en/publications-data/public-health-guidance-screening-and-vaccination-infectious-diseases-newly .
World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. (accessed 22 Dec 2022); https://www.who.int/publications/i/item/9789240053779 .
Crawshaw, A. F. et al. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. Lancet Infect. Dis. 22, E254–E266 (2022).
doi: 10.1016/S1473-3099(22)00066-4
pubmed: 35429463
pmcid: 9007555
Colucci, G. et al. Clinical evaluation of plasma separation cards as a tool to collect, store, and test blood samples for hepatitis B and C serological markers. Clin. Chem. 68, 214–217 (2022).
doi: 10.1093/clinchem/hvab170
Kim, J. U., Ingiliz, P., Shimakawa, Y. & Lemoine, M. Improving care of migrants is key for viral hepatitis elimination in Europe. Bull. World Health Org. 99, 280–286 (2021).
doi: 10.2471/BLT.20.260919
pubmed: 33953445
pmcid: 8085634
Young, J. et al. Evaluation of a program to improve linkage to and retention in care among refugees with hepatitis B virus infection—three U.S. Cities, 2006–2018. MMWR Morb. Mortal. Wkly Rep. 69, 647–650 (2020).
doi: 10.15585/mmwr.mm6921a2
pubmed: 32463810
pmcid: 7269606
Mostert, M. C., Richardus, J. H. & de Man, R. A. Referral of chronic hepatitis B patients from primary to specialist care: making a simple guideline work. J. Hepatol. 41, 1026–1030 (2004).
doi: 10.1016/j.jhep.2004.08.012
pubmed: 15582137
Xiao, Y., Thompson, A. & Howell, J. Point-of-care tests for hepatitis B: an overview. Cells 9, 2233 (2020).
doi: 10.3390/cells9102233
pubmed: 33023265
pmcid: 7650625